MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$11,620K
Net Income
$3,280K
Net Profit Margin
28.23%
EPS
$0.08
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration agreements
11,620
250
-
13,369*
Research and development, net of tax credits
7,502
14,283
20,270
-9,370*
General and administrative
4,548
6,029
7,652
10,348*
Restructuring
1,826
3,384
3,265
-3,202*
Total operating expenses
13,876
23,696
31,187
-2,224*
Gain on sale of technology and other assets
130
5,666
-
-
Gain on termination of collaboration agreement
3,257
-
-
-
Income (gain) from operations
1,131
-17,780
-31,187
15,593*
Other expense, net
-
18
22
-11*
Realized and unrealized (gain) loss on foreign exchange
-41
66
-2
55*
Interest income
2,224
1,236
1,538
2,855*
Other income (expense), net
89
-
-
-
Total other income, net
2,272
1,284
1,514
2,921*
Income (gain) before income taxes
3,403
-16,496
-29,673
18,514*
Income tax expense
145
248
370
-15*
Net income (gain)
3,258
-16,744
-30,043
18,529*
Unrealized loss on available-for-sale marketable securities
-
0
-
-
Unrealized loss (gain) on available-for-sale marketable securities
22
-17
-45
-796
Total other comprehensive income (gain)
22
-17
-45
-796*
Comprehensive income (gain)
3,280
-16,761
-30,088
17,733
Basic EPS
0.08
-0.39
-0.71
0.419
Diluted EPS
0.08
-0.39
-0.71
0.419
Basic Average Shares
42,965,529
42,921,936
42,591,730
42,369,553
Diluted Average Shares
43,051,934
42,921,936
42,591,730
42,369,553
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$2,224K
(-11.46%↓ Y/Y)
Other income
(expense), net
$89K
Collaboration agreements
$11,620K
Gain on termination
of collaboration...
$3,257K
Gain on sale of
technology and other assets
$130K
Total other income,
net
$2,272K
(-7.30%↓ Y/Y)
Income (gain) from
operations
$1,131K
(103.11%↑ Y/Y)
Realized and unrealized
(gain) loss on foreign...
-$41K
(-115.79%↓ Y/Y)
Total operating
expenses
$13,876K
(-61.85%↓ Y/Y)
Income (gain) before
income taxes
$3,403K
(110.03%↑ Y/Y)
Unrealized loss (gain) on
available-for-sale marketable...
$22K
(-91.97%↓ Y/Y)
Research and
development, net of tax...
$7,502K
(-73.59%↓ Y/Y)
General and
administrative
$4,548K
(-29.42%↓ Y/Y)
Restructuring
$1,826K
(19.58%↑ Y/Y)
Net income (gain)
$3,258K
(109.47%↑ Y/Y)
Total other
comprehensive income (gain)
$22K
(-91.97%↓ Y/Y)
Income tax expense
$145K
(-70.10%↓ Y/Y)
Comprehensive income (gain)
$3,280K
(109.61%↑ Y/Y)
Buy us a coffee
Repare Therapeutics Inc. (RPTX)
Repare Therapeutics Inc. (RPTX)